Showing results (11-20 of 3,203) with videos related to
Sort By:
Pageof 321
Journal of Chemotherapy (Florence, Italy)|September 10, 2003
Immune changes in patients with colorectal cancer treated by adjuvant therapy with monoclonal antibody 17-1A: a pilot studyO E Tsitsilonis, N B Tsavaris, C Kosmas, et al.Journal of Chemotherapy (Florence, Italy)|September 10, 2003
Early reappearance of primary solid cancer in patients treated with purine analogsR Fazzi, F Caracciolo, S Galimberti, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Effects of rufloxacin in Salmonella typhimurium infection in miceL Bonina, M Carbone, P Mastroeni, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in childrenR Manfredi, C Jannuzzi, E Mantero, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Clinical use of the new macrolides, azalides, and streptogramins in pediatricsD AdamJournal of Chemotherapy (Florence, Italy)|April 1, 1992
Plasmid profiles of Acinetobacter and Enterobacter species of hospital origin: restriction endonuclease analysis of plasmid DNA and transformation of Escherichia coli by R plasmidsI Spiliopoulou, A Droukopoulou, A Athanassiadou, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitisC A De Abate, R J Perrotta, M L Dennington, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillinC De Simone, V Trinchieri, S Tzantzoglou, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patientsF Barchiesi, A Giacometti, D Arzeni, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Evaluation of toxicity in 22 patients treated with subcutaneous interleukin-2, alpha-interferon with and without chemotherapyR Ridolfi, R Maltoni, A Riccobon, et al.Pageof 321